Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Esperion Theraptc (ESPR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,134,557
  • Shares Outstanding, K 26,790
  • Annual Sales, $ N/A
  • Annual Income, $ -166,990 K
  • 36-Month Beta 2.37
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.32

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.65 +15.55%
on 06/26/18
47.69 -11.20%
on 07/05/18
+1.75 (+4.31%)
since 06/13/18
3-Month
33.06 +28.10%
on 05/03/18
77.99 -45.70%
on 04/17/18
-33.37 (-44.07%)
since 04/13/18
52-Week
33.06 +28.10%
on 05/03/18
82.68 -48.78%
on 02/27/18
-5.10 (-10.75%)
since 07/13/17

Most Recent Stories

More News
After Yesterday's Decline of 3.44%, Esperion Therape Offers Investors Better Value

Esperion Therape (NASDAQ:ESPR) traded in a range yesterday that spanned from a low of $41.85 to a high of $45.24. Yesterday, the shares fell 3.4%, which took the trading range below the 3-day low of...

ESPR : 42.35 (-0.47%)
Options Traders Expect Huge Moves in Esperion Therapeutics (ESPR) Stock

Investors in Esperion Therapeutics (ESPR) need to pay close attention to the stock based on moves in the options market lately.

ESPR : 42.35 (-0.47%)
UPCOMING DEADLINES: The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ESPR, ORA, MFGP, FLR, and REPH

The Klein Law Firm reminds investors that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline...

ESPR : 42.35 (-0.47%)
MFGP : 16.63 (+2.91%)
FLR : 49.45 (+1.15%)
REPH : 5.52 (+1.28%)
ORA : 52.50 (+0.88%)
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Esperion Therapeutics, Inc. (ESPR) and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Michigan on behalf of all persons or entities who purchased...

ESPR : 42.35 (-0.47%)
DEADLINE TOMORROW: The Schall Law Firm Announces it is Investigating Claims Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Esperion Therapeutics, Inc. ("Esperion" or the...

ESPR : 42.35 (-0.47%)
CLASS ACTION UPDATE for ESPR, SYMC, and PPG: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have...

ESPR : 42.35 (-0.47%)
PPG : 103.99 (+0.14%)
SYMC : 21.67 (+0.23%)
24 HOUR DEADLINE NOTICE: Kaskela Law LLC Announces Shareholder Class Action Lawsuit Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $250,000 to Immediately Contact the Firm

A shareholder class action lawsuit has been filed against Esperion Therapeutics, Inc. (NASDAQ: ESPR) ("Esperion" or the "Company") on behalf of investors who purchased the Company's common...

ESPR : 42.35 (-0.47%)
Shares of Zafgen Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (ZFGN, ESPR , CLVS , GBT , TSRO )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

ESPR : 42.35 (-0.47%)
CLVS : 48.53 (+1.51%)
ZFGN : 9.88 (-3.61%)
Notable Tuesday Option Activity: ESPR, WAIR, RGLD

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Esperion Therapeutics Inc , where a total of 4,794 contracts have traded so far, representing...

ESPR : 42.35 (-0.47%)
FRIDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Esperion Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Esperion Therapeutics, Inc. ("Esperion" or "the Company")...

ESPR : 42.35 (-0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade ESPR with:

Business Summary

Esperion Therapeutics, Inc. is a biopharmaceutical company. It focused on the research, development and commercialization of therapies for low-density lipoprotein cholesterol and other cardiometabolic risk factors. Esperion Therapeutics, Inc. is based in Plymouth, Michigan.

See More

Key Turning Points

2nd Resistance Point 44.99
1st Resistance Point 43.67
Last Price 42.35
1st Support Level 41.45
2nd Support Level 40.55

See More

52-Week High 82.68
Fibonacci 61.8% 63.73
Fibonacci 50% 57.87
Fibonacci 38.2% 52.01
Last Price 42.35
52-Week Low 33.06

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar